Table 2:
Open in new tab

Patient characteristics at follow-up

UVF (n = 151)BVF (n = 41)P-valueTotal (N = 192)

Follow-up time (years)

 Mean (SD)

 Median (IQR)

15.3 (10.7)

13.5 (7.3–23.1)

10 (10.3)

5.2 (1.1–18.4)

14.1 (10.8)

12.7 (5.4–20.7)

Late death, n (%)13 (8.6)3 (7.3)0.72b16 (8.3)
Overall morbidity, n (%)70 (46.4)13 (31.7)0.80b83 (43.2)
Late cardiac failure, n (%)12 (10.2)4 (14.3)0.51a16 (11.0)
Liver disease, n (%)9 (7.6)0 (0.0)0.21a9 (6.2)
Pulmonary hypertension, n (%)11 (9.3)4 (14.3)0.49a15 (10.3)
Protein-losing enteropathy, n (%)7 (6.3)1 (3.8)1.00a8 (5.8)
Cardiac rhythm, n (%)Sinus84 (63.2)31 (88.6)0.018a115 (68.4)
Pacemaker28 (21.0)1 (2.9)29 (17.3)
Arrhythmias necessitating direct-current shock7 (5.3)1 (2.9)8 (4.8)
Atrial-junctional rhythm14 (10.5)2 (5.7)16 (9.5)
Surgical reoperations, n (%)26 (17.2)4 (9.8)0.33a30 (15.6)
UVF (n = 151)BVF (n = 41)P-valueTotal (N = 192)

Follow-up time (years)

 Mean (SD)

 Median (IQR)

15.3 (10.7)

13.5 (7.3–23.1)

10 (10.3)

5.2 (1.1–18.4)

14.1 (10.8)

12.7 (5.4–20.7)

Late death, n (%)13 (8.6)3 (7.3)0.72b16 (8.3)
Overall morbidity, n (%)70 (46.4)13 (31.7)0.80b83 (43.2)
Late cardiac failure, n (%)12 (10.2)4 (14.3)0.51a16 (11.0)
Liver disease, n (%)9 (7.6)0 (0.0)0.21a9 (6.2)
Pulmonary hypertension, n (%)11 (9.3)4 (14.3)0.49a15 (10.3)
Protein-losing enteropathy, n (%)7 (6.3)1 (3.8)1.00a8 (5.8)
Cardiac rhythm, n (%)Sinus84 (63.2)31 (88.6)0.018a115 (68.4)
Pacemaker28 (21.0)1 (2.9)29 (17.3)
Arrhythmias necessitating direct-current shock7 (5.3)1 (2.9)8 (4.8)
Atrial-junctional rhythm14 (10.5)2 (5.7)16 (9.5)
Surgical reoperations, n (%)26 (17.2)4 (9.8)0.33a30 (15.6)
a

Fisher’s exact test.

b

Cox regression.

BVF: biventricular Fontan; IQR: interquartile range; SD: standard deviation; UVF: univentricular Fontan.

Boldface are those values which are statistically significant.

Table 2:
Open in new tab

Patient characteristics at follow-up

UVF (n = 151)BVF (n = 41)P-valueTotal (N = 192)

Follow-up time (years)

 Mean (SD)

 Median (IQR)

15.3 (10.7)

13.5 (7.3–23.1)

10 (10.3)

5.2 (1.1–18.4)

14.1 (10.8)

12.7 (5.4–20.7)

Late death, n (%)13 (8.6)3 (7.3)0.72b16 (8.3)
Overall morbidity, n (%)70 (46.4)13 (31.7)0.80b83 (43.2)
Late cardiac failure, n (%)12 (10.2)4 (14.3)0.51a16 (11.0)
Liver disease, n (%)9 (7.6)0 (0.0)0.21a9 (6.2)
Pulmonary hypertension, n (%)11 (9.3)4 (14.3)0.49a15 (10.3)
Protein-losing enteropathy, n (%)7 (6.3)1 (3.8)1.00a8 (5.8)
Cardiac rhythm, n (%)Sinus84 (63.2)31 (88.6)0.018a115 (68.4)
Pacemaker28 (21.0)1 (2.9)29 (17.3)
Arrhythmias necessitating direct-current shock7 (5.3)1 (2.9)8 (4.8)
Atrial-junctional rhythm14 (10.5)2 (5.7)16 (9.5)
Surgical reoperations, n (%)26 (17.2)4 (9.8)0.33a30 (15.6)
UVF (n = 151)BVF (n = 41)P-valueTotal (N = 192)

Follow-up time (years)

 Mean (SD)

 Median (IQR)

15.3 (10.7)

13.5 (7.3–23.1)

10 (10.3)

5.2 (1.1–18.4)

14.1 (10.8)

12.7 (5.4–20.7)

Late death, n (%)13 (8.6)3 (7.3)0.72b16 (8.3)
Overall morbidity, n (%)70 (46.4)13 (31.7)0.80b83 (43.2)
Late cardiac failure, n (%)12 (10.2)4 (14.3)0.51a16 (11.0)
Liver disease, n (%)9 (7.6)0 (0.0)0.21a9 (6.2)
Pulmonary hypertension, n (%)11 (9.3)4 (14.3)0.49a15 (10.3)
Protein-losing enteropathy, n (%)7 (6.3)1 (3.8)1.00a8 (5.8)
Cardiac rhythm, n (%)Sinus84 (63.2)31 (88.6)0.018a115 (68.4)
Pacemaker28 (21.0)1 (2.9)29 (17.3)
Arrhythmias necessitating direct-current shock7 (5.3)1 (2.9)8 (4.8)
Atrial-junctional rhythm14 (10.5)2 (5.7)16 (9.5)
Surgical reoperations, n (%)26 (17.2)4 (9.8)0.33a30 (15.6)
a

Fisher’s exact test.

b

Cox regression.

BVF: biventricular Fontan; IQR: interquartile range; SD: standard deviation; UVF: univentricular Fontan.

Boldface are those values which are statistically significant.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close